(DMAC) Diamedica Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Diamedica Therapeutics | (DMAC) share price targets
Complete technical analysis of Diamedica Therapeutics (DMAC) by charts plus indicators, forecast predictions and share price targets for Diamedica Therapeutics (DMAC)
Diamedica Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2026-02-11 View latest technical analysis
10 day averaged volume of Diamedica Therapeutics is 190020
| Date | Daily Closing Price | Open | High | Low | Volume |
| 11 Wed Feb 2026 | 8.30 | 8.38 | 8.38 | 8.00 | 0.424 times |
| 10 Tue Feb 2026 | 8.36 | 8.15 | 8.78 | 8.04 | 1.548 times |
| 09 Mon Feb 2026 | 8.14 | 8.16 | 8.25 | 7.74 | 0.589 times |
| 06 Fri Feb 2026 | 8.14 | 7.74 | 8.24 | 7.58 | 0.866 times |
| 05 Thu Feb 2026 | 7.54 | 7.85 | 7.99 | 7.47 | 0.766 times |
| 04 Wed Feb 2026 | 7.90 | 8.48 | 8.77 | 7.80 | 1.093 times |
| 03 Tue Feb 2026 | 8.40 | 8.19 | 8.60 | 7.97 | 1.067 times |
| 02 Mon Feb 2026 | 8.18 | 8.04 | 8.38 | 7.95 | 0.675 times |
| 30 Fri Jan 2026 | 8.04 | 8.36 | 8.57 | 7.90 | 1.204 times |
| 29 Thu Jan 2026 | 8.47 | 8.40 | 8.63 | 8.20 | 0.926 times |
My analysis of stock is bullish for shortterm, and stock might move up till 8.6 or till 9. Use a stoploss of 8.21 and if this stock hits its stoploss, then it can fall down till 7.85
Share price targets for Diamedica Therapeutics (DMAC)
| Target Type | Value |
| Downside Target | 5.26 |
| Downside Target | 6.45 |
| Downside Target | 7.17 |
| Downside Target | 7.47 |
| Downside Target | 7.74 |
| Upside Target | 8.64 |
| Upside Target | 8.78 |
| Upside Target | 8.85 |
| Upside Target | 9.00 |
| Upside Target | 9.23 |
| Upside Target | 10.42 |
Intraday share price targets for Diamedica Therapeutics (DMAC)
| Target Type | Value |
| Downside Intraday Target | 7.77 |
| Downside Intraday Target | 7.23 |
| Upside Intraday Target | 8.81 |
| Upside Intraday Target | 9.31 |
| Downside Intraday Target | 8.27 |
Weekly technical analysis of Diamedica Therapeutics (DMAC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 11 Wed Feb 2026 | 8.30 | 8.16 | 8.78 | 7.74 | 0.574 times |
| 06 Fri Feb 2026 | 8.14 | 8.04 | 8.77 | 7.47 | 0.82 times |
| 30 Fri Jan 2026 | 8.04 | 8.49 | 9.00 | 7.90 | 0.747 times |
| 23 Fri Jan 2026 | 8.51 | 7.43 | 8.85 | 7.17 | 1.112 times |
| 16 Fri Jan 2026 | 7.57 | 8.13 | 8.64 | 7.48 | 1.147 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Diamedica Therapeutics (DMAC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 11 Wed Feb 2026 | 8.30 | 8.04 | 8.78 | 7.47 | 0.272 times |
| 30 Fri Jan 2026 | 8.04 | 8.12 | 9.00 | 7.17 | 0.504 times |
| 31 Wed Dec 2025 | 7.96 | 8.62 | 10.42 | 7.76 | 1.015 times |
| 28 Fri Nov 2025 | 8.63 | 6.79 | 9.23 | 5.26 | 1.615 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Diamedica Therapeutics (DMAC)
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Diamedica Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Diamedica Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Diamedica Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Diamedica Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Diamedica Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.16 and Diamedica Therapeutics (DMAC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Diamedica Therapeutics ( (DMAC) ) based on a mid to longer term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
ADX buy sell signal for Diamedica Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a SELL signal for Diamedica Therapeutics in short term but the sell signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Diamedica Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Diamedica Therapeutics in short term but SELL signal is weak.
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Diamedica Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 8.16 and Diamedica Therapeutics (DMAC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Diamedica Therapeutics (DMAC) stock. Volume based technical analysis of Diamedica Therapeutics (DMAC) stock is negative.
Diamedica Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.